Exclusive: New York biotech debuts with $16M to find new ways to make solid cancer cell therapies - Endpoints News
endpts.comSubmitted by endpointsnews6292 in technology
A new biotech is coming out of stealth with $16 million to develop cell therapies for solid cancers — an area where scientists have had limited success. OverT Bio (pronounced